Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jane Freeman

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
The New England Journal of Medicine|March 18, 2006
Epidemic Clostridium difficileMark H Wilcox, Jane Freeman
Infectious Disease Clinics of North America|January 14, 2015
Predictive values of models of Clostridium difficile infectionCaroline H Chilton, Jane Freeman
The Journal of Antimicrobial Chemotherapy|April 30, 2005
Effects of piperacillin/tazobactam on Clostridium difficile growth and toxin production in a human gut modelSimon D Baines, Jane Freeman, Mark H Wilcox
The Journal of Antimicrobial Chemotherapy|May 31, 2003
Effects of cefotaxime and desacetylcefotaxime upon Clostridium difficile proliferation and toxin production in a triple-stage chemostat model of the human gutJane Freeman, Fiona J O'Neill, Mark H Wilcox
Lancet (London, England)|March 28, 2006
Measurement of toxin production by Clostridium difficileJane Freeman, Warren Fawley, Simon Baines, et al.
Gut Microbes|May 5, 2012
Models for the study of Clostridium difficile infectionEmma L Best, Jane Freeman, Mark H Wilcox
Pediatric Neurosurgery|April 26, 2006
CSF shunt failure with stable normal ventricular sizeKen R Winston, John A Lopez, Jane Freeman
Antimicrobial Agents and Chemotherapy|February 19, 2009
Tolevamer is not efficacious in the neutralization of cytotoxin in a human gut model of Clostridium difficile infectionSimon D Baines, Jane Freeman, Mark H Wilcox
Antimicrobial Agents and Chemotherapy|December 21, 2016
<i>In Vitro</i> Activities of MCB3681 and Eight Comparators against Clostridium difficile Isolates with Known Ribotypes and Diverse Geographical SpreadJane Freeman, Sally Pilling, Jonathan Vernon, et al.
Antimicrobial Agents and Chemotherapy|November 11, 2015
Susceptibility of Clostridium difficile Isolates of Varying Antimicrobial Resistance Phenotypes to SMT19969 and 11 ComparatorsJane Freeman, Jonathan Vernon, Richard Vickers, et al.
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
The New England Journal of Medicine|March 18, 2006
Epidemic Clostridium difficileMark H Wilcox, Jane Freeman
Infectious Disease Clinics of North America|January 14, 2015
Predictive values of models of Clostridium difficile infectionCaroline H Chilton, Jane Freeman
The Journal of Antimicrobial Chemotherapy|April 30, 2005
Effects of piperacillin/tazobactam on Clostridium difficile growth and toxin production in a human gut modelSimon D Baines, Jane Freeman, Mark H Wilcox
The Journal of Antimicrobial Chemotherapy|May 31, 2003
Effects of cefotaxime and desacetylcefotaxime upon Clostridium difficile proliferation and toxin production in a triple-stage chemostat model of the human gutJane Freeman, Fiona J O'Neill, Mark H Wilcox
Lancet (London, England)|March 28, 2006
Measurement of toxin production by Clostridium difficileJane Freeman, Warren Fawley, Simon Baines, et al.
Gut Microbes|May 5, 2012
Models for the study of Clostridium difficile infectionEmma L Best, Jane Freeman, Mark H Wilcox
Pediatric Neurosurgery|April 26, 2006
CSF shunt failure with stable normal ventricular sizeKen R Winston, John A Lopez, Jane Freeman
Antimicrobial Agents and Chemotherapy|February 19, 2009
Tolevamer is not efficacious in the neutralization of cytotoxin in a human gut model of Clostridium difficile infectionSimon D Baines, Jane Freeman, Mark H Wilcox
Antimicrobial Agents and Chemotherapy|December 21, 2016
<i>In Vitro</i> Activities of MCB3681 and Eight Comparators against Clostridium difficile Isolates with Known Ribotypes and Diverse Geographical SpreadJane Freeman, Sally Pilling, Jonathan Vernon, et al.
Antimicrobial Agents and Chemotherapy|November 11, 2015
Susceptibility of Clostridium difficile Isolates of Varying Antimicrobial Resistance Phenotypes to SMT19969 and 11 ComparatorsJane Freeman, Jonathan Vernon, Richard Vickers, et al.
Pageof 6